A radiomics model for predicting perineural invasion in stage II-III colon cancer based on computer tomography - PubMed
- ️Mon Jan 01 2024
A radiomics model for predicting perineural invasion in stage II-III colon cancer based on computer tomography
Tairan Guo et al. BMC Cancer. 2024.
Abstract
Background: Colon cancer, a frequently encountered malignancy, exhibits a comparatively poor survival prognosis. Perineural invasion (PNI), highly correlated with tumor progression and metastasis, is a substantial effective predictor of stage II-III colon cancer. Nonetheless, the lack of effective and facile predictive methodologies for detecting PNI prior operation in colon cancer remains a persistent challenge.
Method: Pre-operative computer tomography (CT) images and clinical data of patients diagnosed with stage II-III colon cancer between January 2015 and December 2023 were obtained from two sub-districts of Sun Yat-sen Memorial Hospital (SYSUMH). The LASSO/RF/PCA filters were used to screen radiomics features and LR/SVM models were utilized to construct radiomics model. A comprehensive model, shown as nomogram finally, combining with radiomics score and significant clinical features were developed and validated by area under the curve (AUC) and decision curve analysis (DCA).
Result: The total cohort, comprising 426 individuals, was randomly divided into a development cohort and a validation cohort as a 7:3 ratio. Radiomics scores were extracted from LASSO-SVM models with AUC of 0.898/0.726 in the development and validation cohorts, respectively. Significant clinical features (CA199, CA125, T-stage, and N-stage) were used to establish combining model with radiomics scores. The combined model exhibited superior reliability compared to single radiomics model in AUC value (0.792 vs. 0.726, p = 0.003) in validation cohorts. The radiomics-clinical model demonstrated an AUC of 0.918/0.792, a sensitivity of 0.907/0.813 and a specificity of 0.804/0.716 in the development and validation cohorts, respectively.
Conclusion: The study developed and validated a predictive nomogram model combining radiomics scores and clinical features, and showed good performance in predicting PNI pre-operation in stage II-III colon cancer patients.
Keywords: Colon cancer; PNI; Predictive model; Radiomics.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures

Workflow of the study

The process of model based on radiomics construction

LASSO regression analysis for selection of radiomics features. A λ called penalty factor was gotten after tenfold cross-validation. λ minimum and λ 1-SE were selected to sign the dotted vertical line in the plot. B LASSO coefficient profile for predicting PNI in stage II-III colon cancer

Data of LASSO-SVM radiomics model. A ROC of LASSO-SVM radiomics model of development cohort and validation cohort, respectively. B Radio-score in stage II-III colon cancer with or without PNI. C Radio-score in high or low risk of PNI in stage II-III colon cancer

ROC and decision curve of radiomics-clinical and radiomics models in development and validation cohort. ROC of development cohort (A) and validation cohort (B) of 2 models. Decision curve analysis of development cohort (C) and validation cohort (D) of 2 models

Nomogram of the radiomics-clinical model
Similar articles
-
Tang B, Wu F, Peng L, Leng X, Han Y, Wang Q, Wu J, Orlandini LC. Tang B, et al. Cancer Imaging. 2024 Oct 4;24(1):131. doi: 10.1186/s40644-024-00781-w. Cancer Imaging. 2024. PMID: 39367492 Free PMC article.
-
Liu Y, Sun BJ, Zhang C, Li B, Yu XX, Du Y. Liu Y, et al. World J Gastroenterol. 2024 Apr 28;30(16):2233-2248. doi: 10.3748/wjg.v30.i16.2233. World J Gastroenterol. 2024. PMID: 38690027 Free PMC article.
-
Li Y, Eresen A, Shangguan J, Yang J, Benson AB 3rd, Yaghmai V, Zhang Z. Li Y, et al. J Cancer Res Clin Oncol. 2020 Dec;146(12):3165-3174. doi: 10.1007/s00432-020-03354-z. Epub 2020 Aug 10. J Cancer Res Clin Oncol. 2020. PMID: 32779023
-
Liu SH, Hou XY, Zhang XX, Liu GW, Xin FJ, Wang JG, Zhang DL, Wang DS, Lu Y. Liu SH, et al. Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Nov 25;23(11):1059-1066. doi: 10.3760/cma.j.cn.441530-20200103-00004. Zhonghua Wei Chang Wai Ke Za Zhi. 2020. PMID: 33212554 Chinese.
-
Chen Q, Cui Y, Xue T, Peng H, Li M, Zhu X, Duan S, Gu H, Feng F. Chen Q, et al. Abdom Radiol (NY). 2022 Sep;47(9):3251-3263. doi: 10.1007/s00261-022-03620-3. Epub 2022 Aug 12. Abdom Radiol (NY). 2022. PMID: 35960308
References
-
- Benson AB, Venook AP, Bekaii-Saab T, et al. Colon cancer, Version 3.2014. J Natl Compr Canc Netw. 2014;12:1028–59. - PubMed
-
- Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229–63. - PubMed
-
- Liu Q, Ma Z, Cao Q, et al. Perineural invasion-associated biomarkers for tumor development. Biomed Pharmacother. 2022;155:113691. - PubMed
-
- Liebig C, Ayala G, Wilks JA, et al. Perineural invasion in cancer: a review of the literature. Cancer. 2009;115:3379–91. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous